JPWO2021078835A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021078835A5 JPWO2021078835A5 JP2022523448A JP2022523448A JPWO2021078835A5 JP WO2021078835 A5 JPWO2021078835 A5 JP WO2021078835A5 JP 2022523448 A JP2022523448 A JP 2022523448A JP 2022523448 A JP2022523448 A JP 2022523448A JP WO2021078835 A5 JPWO2021078835 A5 JP WO2021078835A5
- Authority
- JP
- Japan
- Prior art keywords
- amount
- pharmaceutical composition
- composition according
- group
- filler
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EPPCT/EP2019/078905 | 2019-10-23 | ||
| EP2019078905 | 2019-10-23 | ||
| PCT/EP2020/079698 WO2021078835A1 (fr) | 2019-10-23 | 2020-10-22 | Composition pharmaceutique comprenant du sélexipag |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022553313A JP2022553313A (ja) | 2022-12-22 |
| JPWO2021078835A5 true JPWO2021078835A5 (fr) | 2023-10-30 |
Family
ID=75620412
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022523448A Pending JP2022553313A (ja) | 2019-10-23 | 2020-10-22 | セレキシパグを含む医薬組成物 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20220401441A1 (fr) |
| EP (1) | EP4048235A1 (fr) |
| JP (1) | JP2022553313A (fr) |
| KR (1) | KR20220087443A (fr) |
| CN (1) | CN114555088A (fr) |
| AU (1) | AU2020369912A1 (fr) |
| BR (1) | BR112022007207A2 (fr) |
| CA (1) | CA3154802A1 (fr) |
| EC (1) | ECSP22040921A (fr) |
| IL (1) | IL292354A (fr) |
| JO (1) | JOP20220093A1 (fr) |
| MX (1) | MX2022004882A (fr) |
| PE (1) | PE20221455A1 (fr) |
| WO (1) | WO2021078835A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023195957A1 (fr) * | 2022-04-05 | 2023-10-12 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Comprimé pelliculé comprenant du selexi̇pag traité par granulation humide |
| WO2023195953A1 (fr) * | 2022-04-05 | 2023-10-12 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Comprimé pelliculé comprenant du selexi̇pag |
| WO2023195954A1 (fr) * | 2022-04-05 | 2023-10-12 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Comprimé pelliculé comprenant une dispersion solide de sélexi̇pag |
| WO2024144679A2 (fr) * | 2022-12-28 | 2024-07-04 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Formulation en comprimé comprenant du selexi̇pag |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI316055B (fr) | 2001-04-26 | 2009-10-21 | Nippon Shinyaku Co Ltd | |
| DK2246336T3 (da) | 2008-02-28 | 2020-07-20 | Nippon Shinyaku Co Ltd | Fibroseinhibitor |
| WO2009154246A1 (fr) | 2008-06-19 | 2009-12-23 | 日本新薬株式会社 | Agent thérapeutique pour un dysfonctionnement érectile |
| WO2009157397A1 (fr) | 2008-06-23 | 2009-12-30 | 日本新薬株式会社 | Agent thérapeutique pour une lésion au tractus intestinal accompagnant l’administration d’un anti-inflammatoire nonstéroïdien |
| WO2009157396A1 (fr) | 2008-06-23 | 2009-12-30 | 日本新薬株式会社 | Agent thérapeutique pour la sténose du canal spinal |
| CN102065864B (zh) | 2008-06-23 | 2012-11-21 | 日本新药株式会社 | 炎性肠病治疗剂 |
| KR102705198B1 (ko) | 2009-06-26 | 2024-09-11 | 니뽄 신야쿠 가부시키가이샤 | 결정 |
| WO2011024874A1 (fr) | 2009-08-26 | 2011-03-03 | 日本新薬株式会社 | Sels d'addition avec une base |
| EP2741738A1 (fr) | 2011-08-12 | 2014-06-18 | Ascendis Pharma A/S | Composition à libération prolongée de prostacycline |
| US20150272874A1 (en) | 2012-10-29 | 2015-10-01 | Cardio Incorporated | Pulmonary disease-specific therapeutic agent |
| AU2016366073B2 (en) * | 2015-12-02 | 2021-08-26 | Nippon Shinyaku Co., Ltd. | Pharmaceutical composition containing 2-{4-[N-(5,6- diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N- (methylsulfonyl)acetamide |
| JOP20190204A1 (ar) | 2017-03-08 | 2019-09-05 | Actelion Pharmaceuticals Ltd | تركيبة صيدلانية تشتمل على سيليكسيباغ |
| US20200397700A1 (en) * | 2018-02-21 | 2020-12-24 | Nippon Shinyaku Co., Ltd. | Granular composition, production method for granular composition, and dissolution property improvement method for granular composition |
| JP2022532076A (ja) * | 2019-05-06 | 2022-07-13 | アクテリオン ファーマシューティカルズ リミテッド | サルコイドーシス関連肺高血圧症の治療方法 |
-
2020
- 2020-10-22 CA CA3154802A patent/CA3154802A1/fr active Pending
- 2020-10-22 US US17/770,155 patent/US20220401441A1/en active Pending
- 2020-10-22 MX MX2022004882A patent/MX2022004882A/es unknown
- 2020-10-22 IL IL292354A patent/IL292354A/en unknown
- 2020-10-22 JO JOP/2022/0093A patent/JOP20220093A1/ar unknown
- 2020-10-22 EP EP20792448.1A patent/EP4048235A1/fr active Pending
- 2020-10-22 BR BR112022007207A patent/BR112022007207A2/pt unknown
- 2020-10-22 AU AU2020369912A patent/AU2020369912A1/en active Pending
- 2020-10-22 JP JP2022523448A patent/JP2022553313A/ja active Pending
- 2020-10-22 PE PE2022000625A patent/PE20221455A1/es unknown
- 2020-10-22 KR KR1020227012736A patent/KR20220087443A/ko not_active Application Discontinuation
- 2020-10-22 CN CN202080071283.2A patent/CN114555088A/zh active Pending
- 2020-10-22 WO PCT/EP2020/079698 patent/WO2021078835A1/fr unknown
-
2022
- 2022-05-20 EC ECSENADI202240921A patent/ECSP22040921A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6588915B2 (ja) | Ａｚｄ９２９１を含む医薬組成物 | |
| ES2935800T3 (es) | Forma de dosificación oral de ketamina | |
| JP4970452B2 (ja) | メトホルミン徐放性錠剤およびその製造方法 | |
| ES2354030T3 (es) | Preparación farmacéutica sólida que comprende benzacepinas, y procedimiento de producción de la misma. | |
| EP2205279B1 (fr) | Combinaison pharmaceutique d'aliskirène et de valsartane | |
| KR102221846B1 (ko) | 안정성이 개선된 프레가발린을 함유하는 약제학적 조성물 및 이의 제조방법 | |
| KR20100129776A (ko) | 왁스를 포함하는 서방형 제형 | |
| KR20080039876A (ko) | 높은 약물 충진 제형 및 투여형 | |
| JP2020500176A (ja) | 医薬製剤 | |
| US20200330433A1 (en) | Extended release pharmaceutical composition of apremilast | |
| KR20060120596A (ko) | 로피니롤의 신규 제형 | |
| KR20130010044A (ko) | 콜린 알포세레이트 또는 이의 약학적으로 허용되는 염을 포함하는 서방형 약학 조성물 및 이의 제조방법 | |
| WO2010082220A2 (fr) | Composition pharmaceutique à libération prolongée à base de quétiapine et son procédé de préparation | |
| CA3154802A1 (fr) | Composition pharmaceutique comprenant du selexipag | |
| GB2414668A (en) | Sustained release delivery system for tetracycline compounds | |
| KR20190015329A (ko) | 다파글리플로진 공결정의 약학 조성물 | |
| KR20070069105A (ko) | 서방성 제제 | |
| US11576917B2 (en) | Pharmaceutical compositions comprising Ibrutinib | |
| US20100172984A1 (en) | tablet dosage form comprising cetirizine and pseudoephedrine | |
| JP5211040B2 (ja) | ピリジルメチルスルフィニルベンズイミダゾールのための経口速放医薬製剤 | |
| JP2022522005A (ja) | Ｔｂｎ、又はその塩もしくは水和物を含む薬物組成物及びその製造方法 | |
| US20140010883A1 (en) | Controlled release pharmaceutical compositions of selective serotonin reuptake inhibitor | |
| US9561242B2 (en) | Doxycycline composition | |
| JPWO2021078835A5 (fr) | ||
| TWI436760B (zh) | 阿利克侖之蓋崙（ｇａｌｅｎｉｃａｌ）調配物 |